Metalloenzymes that normally perform catalytic antioxidant or radical-degrading functions, as well as small-molecule complexes that mimic them, can also exert pro-oxidant or radical-forming effects depending on the identity of the terminal reductant. Because nitroxyl radicals function as redox active cocatalysts in the aerobic oxidation of alcohols, we hypothesized that catalytic radical reduction could be achieved via the oxidation of biologically-relevant alcohols. Herein we report an organoruthenium complex (Ru1) that catalyzed reduction of 2,2 0 -azino-bis(3-ethylbenzo-thiazoline-6-sulfonate) radical 
Introduction
Reactive oxygen species (ROS) such as superoxide (O 2 À ) and hydrogen peroxide (H 2 O 2 ) can alter the structures and functions of biomolecules 1,2 via DNA base lesion formation, 3 transition metal ion release from proteins, 4 and membrane phospholipid chain degradation. 5 Antioxidants can prevent or attenuate this damage by reacting with ROS to yield less oxidizing, more stable radical or non-radical products. Superoxide dismutase (SOD) and catalase, for example, are metalloenzymes that protect cells by catalyzing the disproportionation of O 2 À and H 2 O 2 , respectively. 6 Synthetic Mn-salen and Mn-porphyrin complexes have demonstrated both SOD and catalase activity, 7 and some have entered phase 1 clinical trials as therapeutics for neurodegenerative and pulmonary diseases. 8 Recent studies have shown that these classes of synthetic Mn complexes can also exert pro-oxidant effects at low ROS concentrations, 9,10 dichotomous behavior that is consistent with the enzymes they mimic. Catalase converts 2H 2 -CHOH-R 2 to R 1 -C(]O)-R 2 using a nitroxyl radical (e.g., TEMPO, n ¼ 1 for Cu, n ¼ 2 for Ru) as the Hc abstracting reagent (iii) and O 2 as the terminal oxidant (iv). By a similar mechanism, a complex could catalyze radical reduction using a biologically relevant non-tertiary alcohol as the terminal reductant (v).
antioxidants or pro-oxidants will be determined by the nature of the terminal reductant.
A catalytic oxidation reaction important in synthetic chemistry is the aerobic oxidation of
that does not cause any (1) over-oxidation to R-COOH or (2) undesired reactions at other functional groups. [19] [20] [21] [22] [23] One strategy employs a copper or ruthenium catalyst in conjunction with a nitroxyl radical, such as 2,2,6,6-tetramethylpiperidinyl-N-oxyl (TEMPO), to oxidize R 1 -CHOH-R 2 to R 1 -C(]O)-R 2 with concomitant formation of TEMPO-H (Scheme 1-iii). Subsequent regeneration of the TEMPO radical occurs with the oxidation of TEMPO-H by O 2 , which functions as the terminal oxidant for this reaction (Scheme 1-iv). Because the TEMPO radical is reduced by R 1 -CHOH-R 2 in the aerobic alcohol oxidation catalytic cycle, we hypothesized that the catalytic reduction of other radicals could also be achieved via the oxidation (i.e., dehydrogenation) of non-tertiary alcohols (Scheme 1-v). Herein we report the validation of this hypothesis with an organoruthenium complex that catalyzes the reduction and inhibits the formation of radicals in buffered aqueous solutions via the oxidation of biologically-relevant non-tertiary alcohols. Given the successes of group 8 transfer hydrogenation catalysts as chemotherapeutics 24, 25 in particular and the burgeoning scope of medicinal applications for transition metalbased catalytic systems [26] [27] [28] in general, we anticipate that the reduction of radicals via the Ru-catalyzed oxidation of alcohols will lead to new strategies for protecting against ROS in vivo.
Results and discussion

Approach and rationale
We recently reported a Ru complex supported by a chelating N-heterocyclic carbene-carboxylate ligand (Ru1, Scheme 2A) that catalyzed the hydrogenation of C]O, C]N and C]C bonds, in which the H 2 transferred was obtained from the oxidation of i-PrOH to acetone. 29 Based on this catalytic chemical reactivity observed with Ru1 and previous reports of other Ru complexes with chelating carboxylate ligands exerting antioxidant effects in cells, which derived from irreversible stoichiometric reactions with nitric oxide, 30, 31 we hypothesized that Ru1 would function as a catalytic antioxidant, reducing radicals using non-tertiary alcohols as terminal reductants. Using methods previously reported by our group, 29, catalytically, but its signicantly slower reactivity compared to Trolox created the appearance that the percent of ABTSc À degraded was dependent on Ru complex concentration and led to the conclusion that the observed radical degradation was non-catalytic.
Catalytic radical reduction in aqueous buffer
As a catalyst for the 1e À reduction of ABTSc À to ABTS 2À , Ru1 itself cannot serve as the terminal reductant for this reaction, a role most likely played by the EtOH solvent for the experiments displayed in Fig. 1 (Fig. 3-iii) , evidence that the electrons needed for the ABTSc À reduction observed in Fig. 1 were ultimately supplied by the EtOH solvent.
If the hypothesis that the oxidation of R 1 -CHOH-R 2 to R 1 -C(]O)-R 2 provides the electrons necessary for the reduction of ABTSc
À to ABTS 2À is correct (i.e., Scheme 1-v), then both the O-H and C-H groups in a -CHOH-moiety will be essential for terminal reductant function. To test this hypothesis, PBS solutions containing 5 mM Ru1 and 50 mM ABTSc À were treated with 50 mM MeOH, i-PrOH, t-BuOH, ethylene glycol (EG) or 1,2-dimethoxyethane (DME) and the ABTSc À concentration was measured. With MeOH, i-PrOH and EG, the ABTSc À concentration began to decrease immediately following addition of the alcohol, indicating that these alcohols could serve as terminal reductants (Fig. S4-S6 †) . In contrast, no ABTSc À reduction was observed with DME or t-BuOH (e.g., Fig. 4-ii) . However, when the addition of 50 mM t-BuOH was followed by 50 mM EtOH, ABTSc À reduction did occur (Fig. 4-iii) , revealing that the lack of reactivity with t-BuOH was not due to catalyst deactivation but rather the inability of t-BuOH to serve as a terminal reductant. Collectively, these results show that the C-H and O-H groups of a -CHOH-moiety are both essential for terminal reductant function, which is consistent with the hypothesis that oxidation of R 1 -CHOH-R 2 to R 1 -C(]O)-R 2 provides the reducing equivalents necessary to convert ABTSc À to ABTS
2À
. Replacing either the C-H group with C-Me or the O-H group with O-Me precludes this oxidation and thus the ability to function as a terminal reductant, which is supported by the lack of ABTSc À reduction observed with t-BuOH and DME.
Biologically-relevant terminal reductants
A wide variety of biomolecules comprise -CHOH-groups, therefore we hypothesized that sugars, amino acids and citric acid cycle metabolites could serve as suitable terminal reductants in Ru1-catalyzed ABTSc À reduction. To test this hypothesis, PBS solutions containing 5 mM Ru1 and 50 mM ABTSc À were treated with 50 mM serine, threonine, glucose, arabinose, malic acid or lactic acid. Reduction of ABTSc À was markedly slower following the addition of the amino acids compared to the sugars, consistent with the greater number of CH-OH groups per molecule in the latter (Fig. 5) . No signicant differences in reactivity were observed between serine and threonine or between glucose and arabinose. Malic acid and lactic acid are metabolites of the citric acid cycle and each comprises a -CHOH-group. However, no ABTSc À reduction occurred following the addition of 50 mM malic acid or lactic acid to 5 mM Ru1 and 50 mM ABTSc À in PBS (Fig. 6 ). Malate and lactate will be the predominant species in pH 7.4 PBS, and these carboxylate anions can function as chelating bidentate ligands, which could potentially disrupt the catalytic activity of Ru1. To prevent catalyst deactivation, the methyl esters of these substrates were used. Addition of 50 mM methyl lactate (Me-lactate) or dimethyl malate (Me 2 -malate) to PBS solutions containing 5 mM Ru1 and 50 mM ABTSc À caused the ABTSc À concentration to decrease rapidly. None of the biologically-relevant alcohols afforded ABTSc À reduction in the ] to increase by 9.9 and 9.7 mM, respectively, with 
